NanoVibronix, Inc. (NAOV)
USD 2.34
(0.86%)
USD 2.34
(0.86%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -3.71 Million USD | 31.88% |
| 2022 | -5.44 Million USD | 61.85% |
| 2021 | -14.28 Million USD | -230.14% |
| 2020 | -4.32 Million USD | 25.34% |
| 2019 | -5.79 Million USD | -39.48% |
| 2018 | -4.15 Million USD | 16.33% |
| 2017 | -4.96 Million USD | -75.38% |
| 2016 | -2.83 Million USD | 1.84% |
| 2015 | -2.88 Million USD | -8.95% |
| 2014 | -2.64 Million USD | -33.08% |
| 2013 | -1.98 Million USD | -56.0% |
| 2012 | -1.27 Million USD | -76.35% |
| 2011 | -723 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -688 Thousand USD | -17.01% |
| 2024 Q1 | -588 Thousand USD | 27.68% |
| 2023 Q2 | -1.07 Million USD | 2.1% |
| 2023 Q1 | -1.09 Million USD | 46.72% |
| 2023 Q3 | -727 Thousand USD | 32.31% |
| 2023 Q4 | -813 Thousand USD | -11.83% |
| 2023 FY | -3.71 Million USD | 31.88% |
| 2022 Q1 | -1.13 Million USD | 54.24% |
| 2022 Q2 | -1.3 Million USD | -15.02% |
| 2022 Q3 | -955 Thousand USD | 26.65% |
| 2022 Q4 | -2.05 Million USD | -115.6% |
| 2022 FY | -5.44 Million USD | 61.85% |
| 2021 Q1 | -4.91 Million USD | -389.25% |
| 2021 Q3 | -6.67 Million USD | -2990.28% |
| 2021 Q4 | -2.47 Million USD | 62.94% |
| 2021 Q2 | -216 Thousand USD | 95.61% |
| 2021 FY | -14.28 Million USD | -230.14% |
| 2020 Q4 | -1 Million USD | -9.0% |
| 2020 Q2 | -1.47 Million USD | -60.37% |
| 2020 FY | -4.32 Million USD | 25.34% |
| 2020 Q1 | -921 Thousand USD | 22.8% |
| 2020 Q3 | -922 Thousand USD | 37.58% |
| 2019 Q1 | -2.67 Million USD | -123.81% |
| 2019 FY | -5.79 Million USD | -39.48% |
| 2019 Q4 | -1.19 Million USD | -46.38% |
| 2019 Q3 | -815 Thousand USD | 26.38% |
| 2019 Q2 | -1.1 Million USD | 58.68% |
| 2018 Q3 | -1.34 Million USD | -63.11% |
| 2018 FY | -4.15 Million USD | 16.33% |
| 2018 Q1 | -789 Thousand USD | 51.92% |
| 2018 Q2 | -824 Thousand USD | -4.44% |
| 2018 Q4 | -1.19 Million USD | 10.94% |
| 2017 FY | -4.96 Million USD | -75.38% |
| 2017 Q1 | -877 Thousand USD | 21.7% |
| 2017 Q2 | -849 Thousand USD | 3.19% |
| 2017 Q3 | -1.59 Million USD | -88.34% |
| 2017 Q4 | -1.64 Million USD | -2.63% |
| 2016 Q1 | -495 Thousand USD | 36.62% |
| 2016 FY | -2.83 Million USD | 1.84% |
| 2016 Q4 | -1.12 Million USD | -84.82% |
| 2016 Q3 | -606 Thousand USD | 0.66% |
| 2016 Q2 | -610 Thousand USD | -23.23% |
| 2015 FY | -2.88 Million USD | -8.95% |
| 2015 Q1 | -630 Thousand USD | 21.25% |
| 2015 Q2 | -434 Thousand USD | 31.11% |
| 2015 Q3 | -1.03 Million USD | -139.4% |
| 2015 Q4 | -781 Thousand USD | 24.83% |
| 2014 Q4 | -800 Thousand USD | -4.44% |
| 2014 FY | -2.64 Million USD | -33.08% |
| 2014 Q1 | -503 Thousand USD | 12.82% |
| 2014 Q2 | -578 Thousand USD | -14.91% |
| 2014 Q3 | -766 Thousand USD | -32.53% |
| 2013 Q4 | -577 Thousand USD | -65.33% |
| 2013 Q3 | -349 Thousand USD | 0.0% |
| 2013 FY | -1.98 Million USD | -56.0% |
| 2013 Q1 | -798 Thousand USD | -243.97% |
| 2012 FY | -1.27 Million USD | -76.35% |
| 2012 Q4 | -232 Thousand USD | 41.12% |
| 2012 Q3 | -394 Thousand USD | 0.0% |
| 2011 FY | -723 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 93.977% |
| BrainsWay Ltd. | -4.19 Million USD | 11.58% |
| Cerus Corporation | -37.48 Million USD | 90.101% |
| Envoy Medical, Inc. | -29.9 Million USD | 87.592% |
| electroCore, Inc. | -18.83 Million USD | 80.296% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 58.068% |
| IceCure Medical Ltd | -14.65 Million USD | 74.672% |
| Inogen, Inc. | -102.44 Million USD | 96.378% |
| OrthoPediatrics Corp. | -20.97 Million USD | 82.307% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 92.954% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 73.002% |
| MaxCyte, Inc. | -37.92 Million USD | 90.214% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 68.709% |
| Nexalin Technology, Inc. | -4.64 Million USD | 20.171% |
| Orthofix Medical Inc. | -151.39 Million USD | 97.549% |
| PAVmed Inc | -64.17 Million USD | 94.217% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 92.927% |
| RxSight, Inc. | -48.6 Million USD | 92.365% |
| Sight Sciences, Inc. | -55.54 Million USD | 93.319% |
| SI-BONE, Inc. | -43.33 Million USD | 91.437% |
| TELA Bio, Inc. | -46.66 Million USD | 92.047% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 92.507% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 72.679% |
| Acutus Medical, Inc. | -81.66 Million USD | 95.456% |
| Talis Biomedical Corporation | -62 Million USD | 94.015% |
| Spectral AI, Inc. | -20.85 Million USD | 82.205% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 93.894% |
| CVRx, Inc. | -41.19 Million USD | 90.992% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 679.666% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 66.126% |
| Bioventus Inc. | -156.23 Million USD | 97.625% |
| Venus Concept Inc. | -37.25 Million USD | 90.038% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 93.714% |
| LivaNova PLC | 17.54 Million USD | 121.15% |
| 908 Devices Inc. | -36.39 Million USD | 89.805% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 98.012% |
| Nemaura Medical Inc. | -14.14 Million USD | 73.762% |
| NeuroPace, Inc. | -32.95 Million USD | 88.74% |
| LENSAR, Inc. | -14.38 Million USD | 74.199% |
| Apyx Medical Corporation | -18.71 Million USD | 80.169% |
| Cutera, Inc. | -162.83 Million USD | 97.721% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 65.734% |
| BioSig Technologies, Inc. | -29.04 Million USD | 87.222% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 95.511% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 83.2% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 105.478% |
| Axonics, Inc. | -6.08 Million USD | 39.044% |
| Outset Medical, Inc. | -172.79 Million USD | 97.852% |
| IRIDEX Corporation | -9.57 Million USD | 61.223% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 96.496% |
| IRadimed Corporation | 17.19 Million USD | 121.585% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 54.985% |
| INVO Bioscience, Inc. | -8.03 Million USD | 53.812% |
| Telesis Bio, Inc. | -47.72 Million USD | 92.224% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 136.23% |
| Varex Imaging Corporation | -47.7 Million USD | 92.22% |
| Quipt Home Medical Corp. | -2.78 Million USD | -33.297% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 67.119% |
| Pulmonx Corporation | -60.84 Million USD | 93.901% |
| Dynatronics Corporation | -2.69 Million USD | -37.561% |
| Modular Medical, Inc. | -17.47 Million USD | 78.758% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 67.41% |
| Semler Scientific, Inc. | 20.58 Million USD | 118.029% |
| InMode Ltd. | 197.91 Million USD | 101.875% |
| Bruker Corporation | 427.2 Million USD | 100.869% |
| Cytosorbents Corporation | -28.5 Million USD | 86.982% |
| DexCom, Inc. | 541.5 Million USD | 100.685% |
| Align Technology, Inc. | 445.05 Million USD | 100.834% |
| Viveve Medical, Inc. | -22.02 Million USD | 83.152% |
| ZimVie Inc. | -393.28 Million USD | 99.056% |
| Movano Inc. | -29.28 Million USD | 87.327% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 69.452% |
| Nexalin Technology, Inc. | -4.64 Million USD | 20.171% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 679.666% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 98.333% |
| Profound Medical Corp. | -28.56 Million USD | 87.01% |
| Insulet Corporation | 206.3 Million USD | 101.799% |
| enVVeno Medical Corporation | -23.51 Million USD | 84.219% |
| Surmodics, Inc. | -11.54 Million USD | 67.848% |
| iCAD, Inc. | -4.84 Million USD | 23.437% |
| Nuwellis, Inc. | -20.2 Million USD | 81.637% |
| Biotricity, Inc. | -14.09 Million USD | 73.67% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 96.993% |
| Aethlon Medical, Inc. | -12.2 Million USD | 69.602% |
| InspireMD, Inc. | -19.91 Million USD | 81.367% |
| PAVmed Inc. | -64.17 Million USD | 94.217% |
| BIOLASE, Inc. | -20.63 Million USD | 82.013% |
| Beyond Air, Inc. | -60.24 Million USD | 93.84% |
| FONAR Corporation | 10.56 Million USD | 135.117% |
| AxoGen, Inc. | -21.71 Million USD | 82.911% |
| Vivani Medical, Inc. | -25.65 Million USD | 85.533% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 113.014% |
| Inari Medical, Inc. | -1.63 Million USD | -126.834% |
| UFP Technologies, Inc. | 44.92 Million USD | 108.261% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | 27.694% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | 43.817% |
| Tenon Medical, Inc. | -15.58 Million USD | 76.183% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 75.943% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 89.497% |
| AdaptHealth Corp. | -678.89 Million USD | 99.453% |
| Sintx Technologies, Inc. | -8.25 Million USD | 55.067% |
| Quanterix Corporation | -32.33 Million USD | 88.523% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 67.119% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 865.155% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 98.79% |
| TransMedics Group, Inc. | -25.02 Million USD | 85.173% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 83.233% |
| NeuroMetrix, Inc. | -6.52 Million USD | 43.166% |
| Hyperfine, Inc. | -44.23 Million USD | 91.611% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 95.273% |
| Biomerica, Inc. | -5.97 Million USD | 37.922% |
| Bone Biologics Corporation | -8.94 Million USD | 58.53% |
| AVITA Medical, Inc. | -39.16 Million USD | 90.525% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 62.718% |
| Silk Road Medical, Inc | -55.74 Million USD | 93.343% |